An assessment of selected sub-systems of the Egyptian Norplant® program

El-Zanaty, Fatma; Nawar, L; Hamed, Ramadan

doi:10.31899/rh4.1135

Cited by 7 publications

(12 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Middle East and North Africa (MENA) region appears to have the highest prevalence of hepatitis C virus (HCV) worldwide [ 1 , 2 ]. The highest national prevalence of HCV globally is found in Egypt (14.7%) [ 3 , 4 ]. Questions remain as to the prevalence of HCV in the rest of North Africa and to what extent, if any, are this region’s rates influenced by the large HCV reservoir in Egypt.…”

Section: Introductionmentioning

confidence: 99%

The Epidemiology of Hepatitis C Virus in the Maghreb Region: Systematic Review and Meta-Analyses

et al. 2015

View full text Add to dashboard Cite

ObjectiveTo systematically review and synthesize available epidemiological data on hepatitis C virus (HCV) prevalence and incidence in the Maghreb region and to estimate the country-specific population-level HCV prevalence.MethodsWe conducted a systematic review of HCV antibody prevalence and incidence in the Maghreb countries as outlined by the PRISMA guidelines. Meta-analyses were conducted using DerSimonian-Laird random-effect models with inverse variance weighting to pool HCV prevalence estimates among general population groups.ResultsWe identified 133 HCV prevalence measures and two HCV incidence measures. Among high risk groups, HCV prevalence ranged between 22% and 94% among people who inject drugs, 20% and 76% among dialysis patients, and 2% and 51% among hemophiliacs. Among intermediate-risk groups, considerable but widely variable HCV prevalence was found. Most common risk factors cited across studies were the duration of dialysis, number of transfusions, and having a history of surgery or dental work. The national HCV prevalence in Algeria was estimated at 0.3% (95%CI: 0.1–0.5), Libya 1.2% (95%CI: 1.1–1.3), Mauritania 1.1% (95%CI: 0–2.3), Morocco 0.8% (95%CI: 0.5–1.2), and Tunisia 0.6% (95%CI: 0.5–0.8).ConclusionsHCV prevalence in the Maghreb region of the Middle East and North Africa is comparable to that in developed countries of about 1%. HCV exposures appear often to be linked to medical care and are suggestive of ongoing transmission in such settings. Injecting drug use appears also to be a major, though not dominant, contributor to HCV transmission. Further research is needed to draw a more thorough understanding of HCV epidemiology, especially in the countries with limited number of studies. HCV prevention policy and programming in these countries should focus on the settings of exposure.

show abstract

Section: Introductionmentioning

confidence: 99%

The Epidemiology of Hepatitis C Virus in the Maghreb Region: Systematic Review and Meta-Analyses

et al. 2015

View full text Add to dashboard Cite

show abstract

“…The prevalence of HCV infection varies throughout the world, with the highest prevalence (14.7%) reported in Egypt [1]. More than 70% of HCV-infected individuals develop chronic disease, which can progress to liver cirrhosis and hepatocellular carcinoma (HCC).…”

Section: Introductionmentioning

confidence: 99%

Helicobacter Pylori DNA in Liver Tissues From Chronic Hepatitis C Egyptian Patients

et al. 2011

View full text Add to dashboard Cite

BackgroundHepatitis C virus (HCV) is considered the most common etiology of chronic liver disease in Egypt, which may progress to cirrhosis and hepatocellular carcinoma (HCC). Previous studies have documented an association between Helicobacter pylori (H. pylori) infection and liver cirrhosis with or without HCC. This study aimed to investigate the presence of H. pylori DNA in the liver tissue of Egyptian patients with chronic hepatitis C (CHC).MethodsFifty-two CHC Egyptian patients were enrolled in this study. Plasma anti-H. pylori IgG was assessed with ELISA. Liver biopsies were tested for presence of Helicobacter DNA using genus specific nested polymerase chain reaction (PCR) and species was identified by sequencing.ResultsAnti-H. pylori IgG was detected in 31/52 (59.6%) CHC patients while Helicobacter DNA was detected in 6 (11.5%) patients, all were H. Pylori by sequencing. Helicobacter DNA was more frequent in patients with high stage liver fibrosis (33.3%) than in those with low stage fibrosis (2.7%) (P = 0.006). There was no association between the presence of H. pylori DNA in the liver and age, gender of patients, liver function tests, AFP levels or viral load.ConclusionsThese data confirm the presence of H. pylori DNA in liver of some CHC Egyptian patients and suggest an association of this bacterium with progression of liver fibrosis.

show abstract

“…The children of mothers who worked had higher prevalence of stunting as compared to mothers who did not; these findings were not apparent in the EDHS 2008, which showed no difference in stunting rates according to the work status of mothers. 2 The EDHS 2014 did not present the stunting prevalence according to the work status of the mother. 3 Seedhom et al reported in more detail that the mean height for age zscore differed according to the type of maternal occupation.…”

Section: Discussionmentioning

confidence: 99%

“…The EDHS 2008 reported that overall, the prevalence of stunting among Egyptian children under five was 29 percent of children. 2 More recently, the EDHS 2014 showed that stunting levels have appeared to decrease over the previous period, to 21.4%, which is however still considerable. 3 The prevalence of stunting among the present study group was found to be 15.8%, which is somewhat lower than that reported for urban governorates in the EDHS 2014 (19%).…”

Section: Discussionmentioning

confidence: 99%

Stunting among Children Attending a Pediatrics Outpatient Clinic in Cairo, Egypt

2017

The Egypt. J. of Community Medicine

View full text Add to dashboard Cite

Background: Stunting is a considerable problem in developing countries, contributing to increasing under-five mortality, while children of stunted mothers have a higher risk of stunting. Objective: to determine the prevalence and risk factors of stunting among children aged 1-12 years attending the outpatient Paediatrics clinic of Al-Azhar University Hospital (Al-Hussein), Cairo. Participants and methods: the anthropometric measurements of 800 children aged 1-12 years with no history of chronic diseases attending the paediatrics outpatient clinic of Al-Hussein Hospital were recruited and a short questionnaire was administered. Results: the prevalence of stunting was 15.8% with no sex variation. Stunting was found to be associated with parental consanguinity, mother's employment status, and a family history of short stature. Conclusion: there is considerable stunting prevalence rate among this study group. The public should be educated about the importance of avoiding consanguineous marriage. It is important to reduce stunting, especially among girls, to prevent their children from in turn being stunted.

show abstract

An assessment of selected sub-systems of the Egyptian Norplant® program

Cited by 7 publications

References 2 publications

The Epidemiology of Hepatitis C Virus in the Maghreb Region: Systematic Review and Meta-Analyses

The Epidemiology of Hepatitis C Virus in the Maghreb Region: Systematic Review and Meta-Analyses

Helicobacter Pylori DNA in Liver Tissues From Chronic Hepatitis C Egyptian Patients

Stunting among Children Attending a Pediatrics Outpatient Clinic in Cairo, Egypt

Contact Info

Product

Resources

About